These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 983820)

  • 1. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the effect of fibrinopeptides A and B on the central nervous system.
    Bernacka I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):407-14. PubMed ID: 7329866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the role of catecholamines in the action of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):367-76. PubMed ID: 6664939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some pharmacological and biochemical effects of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Stasiak A; Maciejewski A; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):359-66. PubMed ID: 6664938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of antiinflammatory activity of fibrinogen and fibrinopeptides in rats.
    Ruhenstroth-Bauer G; Scherer R; Hornberger M; Tongendorff G
    Inflammation; 1981 Dec; 5(4):343-51. PubMed ID: 7327698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro.
    Moore PK; Hussaini I; Bhardwaj R
    Eur J Pharmacol; 1988 Aug; 153(2-3):231-8. PubMed ID: 3053211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nomifensine and body temperature of the rat: interaction with reserpine, chlorpromazine and amphetamine].
    Puche E; Mundo A; García Morillas M; Baeyens JM; Bolaños J
    Arch Farmacol Toxicol; 1979 Aug; 5(2):123-32. PubMed ID: 533317
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of certain effects of amphetamine by chlorpromazine.
    Borella L; Herr F; Wojdan A
    Can J Physiol Pharmacol; 1969 Jan; 47(1):7-13. PubMed ID: 5761849
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of fibrinogen degradation products (FDP) on the central nervous system and on the effects of centrally acting drugs.
    Buczko W; Moniuszko-Jakoniuk J
    Pharmacology; 1975; 13(3):252-9. PubMed ID: 1153509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute treatment with amphetamine in locomotor activity in sepsis survivor rats.
    Comim CM; Constantino LS; Petronilho F; de Souza B; Barichello T; Quevedo J; Dal-Pizzol F
    J Neuroimmunol; 2009 Jul; 212(1-2):145-7. PubMed ID: 19423170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.